Øyvind S. Bruland

in 1988 when he was 32 years old. Bruland holds a B.Sc., M.D and Ph.D. from the University of Oslo, Norway. His research includes: primary bone and soft tissue cancers (sarcomas) and skeletal metastases from prostate cancer and breast cancer; targeted radionuclide therapy, for instance the clinical development of Alpharadin, based on Radium-223; the tumor biology and prognostic impact of micro-metastases in bone-marrow aspirates on patients with primary bone cancer (osteosarcoma); external beam radiotherapy; and the radiotherapy of skeletal metastases and soft-tissue sarcomas.

He has served as supervisor to twelve Ph.D. students, nine so far having completed their Ph.D. theses. In 2008 he was elected as a member of the Norwegian Academy of Science and Letters. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Øyvind S. Bruland', query time: 0.01s Refine Results
  1. 1
    Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers

    Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers by José M. Lopes, Einar Hannisdal, Bodil Bjerkehagen, Øyvind S. Bruland, Håvard E. Danielsen, Erik O. Pettersend, Manuel Sobrinho-Simões, Jahn M. Nesland

    Published 1998-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin

    Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin by Yngvar Fløisand, Klaus Beiske, Geir Erland Tjønnfjord, Dag Heldal, Bodil Bjerkehagen, Mona-Elisabeth Revheim, Sverre Heim, Øyvind Sverre Bruland, Kirsten Sundby Hall, Anne Tierens, Jan Delabie

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: